S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NASDAQ:AMRN

Amarin News Headlines

$5.01
+0.08 (+1.62 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.88
Now: $5.01
$5.02
50-Day Range
$4.04
MA: $4.68
$5.15
52-Week Range
$3.36
Now: $5.01
$26.12
Volume4.27 million shs
Average Volume9.71 million shs
Market Capitalization$1.96 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.66

Headlines

Amarin (NASDAQ AMRN) News Headlines Today

Source:
SourceHeadline
Amarin (NASDAQ:AMRN) Rating Lowered to Strong Sell at BidaskClubAmarin (NASDAQ:AMRN) Rating Lowered to Strong Sell at BidaskClub
marketbeat.com - October 29 at 4:12 AM
Amarin (NASDAQ:AMRN) Research Coverage Started at JPMorgan Chase & Co.Amarin (NASDAQ:AMRN) Research Coverage Started at JPMorgan Chase & Co.
marketbeat.com - September 29 at 7:30 AM
Amarin Stock Needs Everything to Break The Right Way (AMRN)Amarin Stock Needs Everything to Break The Right Way (AMRN)
marketbeat.com - August 4 at 11:37 AM
Amarin Corporation plc (AMRN) CEO John Thero Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference Call - (Transcript) - Seeking AlphaAmarin Corporation plc (AMRN) CEO John Thero Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference Call - (Transcript) - Seeking Alpha
seekingalpha.com - December 2 at 4:59 PM
Amarin Files Patent Infringement Lawsuit Against Hikma - GlobeNewswireAmarin Files Patent Infringement Lawsuit Against Hikma - GlobeNewswire
globenewswire.com - November 30 at 9:59 PM
Amarin (NASDAQ:AMRN) Trading 7.8% Higher Amarin (NASDAQ:AMRN) Trading 7.8% Higher
americanbankingnews.com - November 30 at 7:18 PM
Amarin to Present at Piper Sandlers 32nd Annual Healthcare Conference (Virtual) - GlobeNewswireAmarin to Present at Piper Sandler's 32nd Annual Healthcare Conference (Virtual) - GlobeNewswire
globenewswire.com - November 24 at 9:34 AM
Amarin to Present at Piper Sandler’s 32nd Annual Healthcare Conference (Virtual)Amarin to Present at Piper Sandler’s 32nd Annual Healthcare Conference (Virtual)
finance.yahoo.com - November 24 at 9:34 AM
Amarin: Theres Still Some Fight Left In This Stock - Seeking AlphaAmarin: There's Still Some Fight Left In This Stock - Seeking Alpha
seekingalpha.com - November 23 at 6:28 PM
Buy Amarin And Bet On Its Recovery In 2021 - Seeking AlphaBuy Amarin And Bet On Its Recovery In 2021 - Seeking Alpha
seekingalpha.com - November 23 at 8:26 AM
Amarin vs. the Generics: Who Will Win? - Motley FoolAmarin vs. the Generics: Who Will Win? - Motley Fool
fool.com - November 22 at 9:21 AM
Amarin stock rise 23% on positive late-stage data in VASCEPA trial in ChinaAmarin stock rise 23% on 'positive' late-stage data in VASCEPA trial in China
seekingalpha.com - November 20 at 7:41 PM
Amarin Jumps on Heart-Drug Progress in China TrialAmarin Jumps on Heart-Drug Progress in China Trial
thestreet.com - November 20 at 7:41 PM
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger - Yahoo FinanceThe Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger - Yahoo Finance
finance.yahoo.com - November 20 at 2:41 PM
ROCE Insights For Amarin Corp - BenzingaROCE Insights For Amarin Corp - Benzinga
benzinga.com - November 20 at 2:41 PM
Amarin (NASDAQ:AMRN) Shares Gap Up to $4.54Amarin (NASDAQ:AMRN) Shares Gap Up to $4.54
americanbankingnews.com - November 20 at 11:02 AM
BUZZ-U.S. STOCKS ON THE MOVE-Amarin Corp, Reeds, AVROBIO - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Amarin Corp, Reed's, AVROBIO - Nasdaq
nasdaq.com - November 20 at 8:48 AM
Amarin Shares Topline Data from Partners Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China - GlobeNewswireAmarin Shares Topline Data from Partner's Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China - GlobeNewswire
globenewswire.com - November 20 at 12:37 AM
Amarin Corporation PLC (AMRN) Presents at Jefferies Virtual London Healthcare Broker Conference Call - (Transcript) - Seeking AlphaAmarin Corporation PLC (AMRN) Presents at Jefferies Virtual London Healthcare Broker Conference Call - (Transcript) - Seeking Alpha
seekingalpha.com - November 19 at 7:37 PM
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China - Yahoo FinanceAmarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China - Yahoo Finance
finance.yahoo.com - November 19 at 7:37 PM
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland ChinaAmarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
finance.yahoo.com - November 19 at 7:37 PM
Multiple New VASCEPA(R) (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Associations Virtual Scientific Sessions 2020Multiple New VASCEPA(R) (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association's Virtual Scientific Sessions 2020
marketwatch.com - November 19 at 9:35 AM
Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Associations Virtual Scientific Sessions 2020 - GlobeNewswireMultiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association's Virtual Scientific Sessions 2020 - GlobeNewswire
globenewswire.com - November 18 at 8:27 AM
Amarin Corp. (AMRN) Announces Multiple New VASCEPA-Related Scientific Findings Presented at AHA - StreetInsider.comAmarin Corp. (AMRN) Announces Multiple New VASCEPA-Related Scientific Findings Presented at AHA - StreetInsider.com
streetinsider.com - November 18 at 8:27 AM
Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scientific Sessions 2020Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scientific Sessions 2020
finance.yahoo.com - November 18 at 8:27 AM
Amarin Corp. (AMRN) VASCEPA Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures - StreetInsider.comAmarin Corp. (AMRN) VASCEPA Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures - StreetInsider.com
streetinsider.com - November 13 at 11:07 PM
Amarin (NASDAQ:AMRN) Stock Price Up 5.9%Amarin (NASDAQ:AMRN) Stock Price Up 5.9%
americanbankingnews.com - November 13 at 7:41 PM
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Associations Virtual Scientific Sessions 2020 - GlobeNewswireVASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association's Virtual Scientific Sessions 2020 - GlobeNewswire
globenewswire.com - November 13 at 6:06 PM
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association’s Virtual Scientific Sessions 2020VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association’s Virtual Scientific Sessions 2020
finance.yahoo.com - November 13 at 1:05 PM
Amarin Co. plc (NASDAQ:AMRN) CEO John F. Thero Sells 153,840 SharesAmarin Co. plc (NASDAQ:AMRN) CEO John F. Thero Sells 153,840 Shares
americanbankingnews.com - November 12 at 11:34 PM
Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences - Yahoo FinanceAmarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences - Yahoo Finance
finance.yahoo.com - November 11 at 5:12 PM
Amarin to Present at the Stifel 2020 Virtual Healthcare and  Jefferies Virtual London Healthcare ConferencesAmarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences
finance.yahoo.com - November 11 at 5:12 PM
Good Entry Point for Amarin Stock? Not Just Yet, Says Analyst - Yahoo FinanceGood Entry Point for Amarin Stock? Not Just Yet, Says Analyst - Yahoo Finance
finance.yahoo.com - November 9 at 8:14 PM
Good Entry Point for Amarin Stock? Not Just Yet, Says AnalystGood Entry Point for Amarin Stock? Not Just Yet, Says Analyst
finance.yahoo.com - November 9 at 8:14 PM
Amarins (AMRN) Q3 Earnings Lag, Sales In Line, Stock Down - Yahoo FinanceAmarin's (AMRN) Q3 Earnings Lag, Sales In Line, Stock Down - Yahoo Finance
finance.yahoo.com - November 6 at 10:23 PM
Amarins (AMRN) Q3 Earnings Lag, Sales In Line, Stock Down - NasdaqAmarin's (AMRN) Q3 Earnings Lag, Sales In Line, Stock Down - Nasdaq
nasdaq.com - November 6 at 5:22 PM
Amarin slips 4% on Q3 results; top-line +39%Amarin slips 4% on Q3 results; top-line +39%
seekingalpha.com - November 6 at 12:21 PM
Amarins (AMRN) Q3 Earnings Lag, Sales In Line, Stock DownAmarin's (AMRN) Q3 Earnings Lag, Sales In Line, Stock Down
finance.yahoo.com - November 6 at 12:21 PM
Amarin (AMRN) Q3 2020 Earnings Call TranscriptAmarin (AMRN) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 6 at 1:30 AM
Amarin Corp: Q3 Earnings Insights - Yahoo FinanceAmarin Corp: Q3 Earnings Insights - Yahoo Finance
finance.yahoo.com - November 5 at 3:28 PM
Are Institutions Heavily Invested In Amarin Corporation plcs (NASDAQ:AMRN) Shares? - Yahoo FinanceAre Institutions Heavily Invested In Amarin Corporation plc's (NASDAQ:AMRN) Shares? - Yahoo Finance
finance.yahoo.com - November 5 at 3:28 PM
Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update - GlobeNewswireAmarin Reports Third Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire
globenewswire.com - November 5 at 3:28 PM
Amarin Corp: Q3 Earnings InsightsAmarin Corp: Q3 Earnings Insights
finance.yahoo.com - November 5 at 3:28 PM
Looking Into Amarin Corps Return On Capital EmployedLooking Into Amarin Corp's Return On Capital Employed
finance.yahoo.com - November 5 at 3:28 PM
Amarin EPS in-line, beats on revenueAmarin EPS in-line, beats on revenue
seekingalpha.com - November 5 at 8:22 AM
Are Institutions Heavily Invested In Amarin Corporation plcs (NASDAQ:AMRN) Shares?Are Institutions Heavily Invested In Amarin Corporation plc's (NASDAQ:AMRN) Shares?
finance.yahoo.com - November 5 at 8:21 AM
Amarin Reports Third Quarter 2020 Financial Results and Provides Business UpdateAmarin Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 5 at 8:21 AM
Amarin Q3 2020 Earnings Preview - Seeking AlphaAmarin Q3 2020 Earnings Preview - Seeking Alpha
seekingalpha.com - November 4 at 2:18 PM
New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Associations Virtual Scientific Sessions 2020 - GlobeNewswireNew VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Association's Virtual Scientific Sessions 2020 - GlobeNewswire
globenewswire.com - October 29 at 9:05 AM
New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Association’s Virtual Scientific Sessions 2020New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Association’s Virtual Scientific Sessions 2020
finance.yahoo.com - October 29 at 9:05 AM
Amarin's Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest StudyAmarin's Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest Study
finance.yahoo.com - October 27 at 10:07 PM
Amarins Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest Study - Motley FoolAmarin's Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest Study - Motley Fool
fool.com - October 26 at 8:39 PM
Amarins Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest StudyAmarin's Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest Study
finance.yahoo.com - October 26 at 8:39 PM
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.